Altimmune, Inc. (NASDAQ:ALT), a biopharmaceutical company with a market capitalization of $503.56 million focused on ...

She was the classic case of being skinny fat, a person who has normal body weight but has a high percentage of body fat ...

Additionally, the concept of sarcopenic obesity—where individuals have both excess body fat and low muscle mass—has gained attention in geriatric research. A consensus statement from leading ...

BIO-101 (SARCONEOS) is under development for the treatment of acute respiratory distress syndrome (ARDS) associated with COVID-19 pneumonia and COVID-19 induced respiratory failure, age-related ...

She was the classic case of being skinny fat, a person who has normal body weight but has a high percentage of body fat ...

Recent findings indicate that widely used weight-loss medications might lead to muscle loss, including vital heart muscle, ...

NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Noom, the leading digital healthcare company committed to chronic disease ...

Jan. 21, 2025 — When children with obesity undergo weight-loss treatment, the effects have repercussions later in life and the risk of serious health problems and premature death is lower as ...

Sarcopenic dysphagia is a condition that affects many older adults, characterized by difficulty swallowing due to the loss of muscle mass and strength in the muscles involved in swallowing.

Recently, an international commission proposed a revised definition of obesity that focuses on how excess body fat affects the body, and factors in waist circumference, rather than simply ...